2021-09-14 08:00
Biovica, active in cancer diagnostics, today announces that DiviTumTKa results from the large BioItaLEE study will be presented as a poster during the European Society for Medical Oncology (ESMO) meeting 16 to 21 September 2021. The results strengthen...
2021-09-13 08:07
Biovica, active in cancer diagnostics, today announced that the company’s expected timeline for its updated 510(k)-application to the US Food and Drug Administration (FDA) has been prolonged due to delay in response from FDA.
2021-08-31 11:20
The annual general meeting of Biovica International AB ("Biovica" or the "Company") was held today on 31 August 2021 and the following resolutions were passed by the meeting.
2021-08-31 08:00
Significant events during the first quarter Significant events after the end of the period Audiocast: When: 2 September 2021 at 10:00 AM CET Where: https://tv.streamfabriken.com/biovica-international-q1-2021-2022 Phone numbers: SE: +46850558365, DK: +4578150108...
2021-08-27 14:30
Biovica, active in cancer diagnostics, today announced that a pre-recorded presentation with CEO Anders Rylander has been published.
2021-08-10 08:00
Biovica, active in cancer diagnostics, today announced that Warren Cresswell has been appointed President Americas and will be part of the management team.
2021-07-30 11:15
The shareholders of Biovica International AB, reg. no. 556774-6150, (the "Company") are hereby invited to the annual general meeting on Tuesday 31 August 2021.
2021-06-30 08:00
Annual report for the financial year 2020/2021 for Biovica International AB is published today on our website
2021-06-17 08:00
Preparations for the launch of DiviTum®TKa
2021-05-22 14:30
Biovica, active in cancer diagnostics, will host a virtual Capital Markets Day on Wednesday 9 June from 14.00 to 16.30.
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects